The regulation of muscle mass by endogenous glucocorticoids

被引:179
|
作者
Braun, Theodore P. [1 ,2 ]
Marks, Daniel L. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
加拿大健康研究院;
关键词
glucococorticoids; muscle; skeletal; HPA-axis; cachexia; catabolism; wasting; protein synthesis; 1 NULL MICE; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; PROTEIN-DEGRADATION; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; CANCER CACHEXIA; ATROPHY INVOLVE;
D O I
10.3389/fphys.2015.00012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiguitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Endogenous Glucocorticoids Inhibit Myocardial Inflammation Induced by Lipopolysaccharide: Involvement of Regulation of Histone Deacetylation
    Zhang, Hai-Ning
    He, Yan-Hua
    Zhang, Gen-Shui
    Luo, Miao-Shan
    Huang, Yue
    Wu, Xiao-qian
    Liu, Shi-Ming
    Luo, Jian-Dong
    Chen, Min-Sheng
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (01) : 33 - 41
  • [22] ARE ENDOGENOUS GLUCOCORTICOIDS INVOLVED IN SHORT-TERM REGULATION OF HEPATIC GLYCOGEN-METABOLISM
    VISKUPIC, E
    NEMETH, S
    ENDOCRINOLOGIA EXPERIMENTALIS, 1985, 19 (04): : 283 - 289
  • [23] Molecular regulation of skeletal muscle mass
    Russell, Aaron P.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (03) : 378 - 384
  • [24] Regulation of Muscle Mass by Follistatin and Activins
    Lee, Se-Jin
    Lee, Yun-Sil
    Zimmers, Teresa A.
    Soleimani, Arshia
    Matzuk, Martin M.
    Tsuchida, Kunihiro
    Cohn, Ronald D.
    Barton, Elisabeth R.
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (10) : 1998 - 2008
  • [25] Endogenous CSE/Hydrogen Sulfide System Regulates the Effects of Glucocorticoids and Insulin on Muscle Protein Synthesis
    Wang, Ruxia
    Li, Kelin
    Wang, Hui
    Jiao, Hongchao
    Wang, Xiaojuan
    Zhao, Jingpeng
    Lin, Hai
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [26] INVOLVEMENT OF ENDOGENOUS GLUCOCORTICOIDS IN THE REGULATION OF IL-1 AND TNF EXPRESSION DURING ENDOTOXIN TOLERANCE
    EVANS, GF
    ZUCKERMAN, SH
    LYMPHOKINE RESEARCH, 1990, 9 (04): : 580 - 580
  • [27] Regulation of Lipid Metabolism by Glucocorticoids and 11β-HSD1 in Skeletal Muscle
    Morgan, Stuart A.
    Gathercole, Laura L.
    Simonet, Claire
    Hassan-Smith, Zaki K.
    Bujalska, Iwona
    Guest, Phil
    Abrahams, Lianne
    Smith, Dave M.
    Stewart, Paul M.
    Lavery, Gareth G.
    Tomlinson, Jeremy W.
    ENDOCRINOLOGY, 2013, 154 (07) : 2374 - 2384
  • [28] DIETARY ENERGY, GLUCOCORTICOIDS AND THE REGULATION OF LONG-BONE AND MUSCLE GROWTH IN THE RAT
    TIRAPEGUI, JO
    YAHYA, ZAH
    BATES, PC
    MILLWARD, DJ
    CLINICAL SCIENCE, 1994, 87 (05) : 599 - 606
  • [29] Glucocorticoids and Skeletal Muscle
    Bodine, Sue C.
    Furlow, J. David
    GLUCOCORTICOID SIGNALING: FROM MOLECULES TO MICE TO MAN, 2015, 872 : 145 - 176
  • [30] Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis
    Leech, M
    Metz, C
    Bucala, R
    Morand, EF
    ARTHRITIS AND RHEUMATISM, 2000, 43 (04): : 827 - 833